About us

Out of complexity we create precision

Owkin is an AI biotech that unlocks complex biology to find the right treatment for every patient
Get in touch
Video
Understanding Owkin  [02:30]

What we believe

Transforming drug discovery and development

Owkin was founded by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, PhD, a pioneer in the field of machine learning in biology, in 2016.

We use AI to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes.

Why work with Owkin

02
Owkin is founder-led
Thomas Clozel, MD, Oncologist, and Gilles Wainrib, PhD, Professor of Machine Learning
07
Global reach
Locations in Boston, New York, London, Paris, Nantes, Geneva and Berlin
03
Trusted by top 8 biopharmas
Strategic deals with:
Sanofi - AI drug discovery
BMS - AI drug development 
MSD - AI diagnostics 
357
Top team 
Leading experts in data access & data science, medical doctors, biostatisticians, and computational biologists 
10
Scientifically robust
Scientific Advisory Board of the best specialists in their disease area, chaired by Miriam Merad (M.D., Ph.D. Mount Sinai School of Medicine, NYC)
02
First-in-class AI diagnostic
CE-marked MSIntuit® CRC screens for MSI in colorectal cancer with only digitized H&E slides
RlapsRisk® BC helps pathologists and oncologists determine the right treatment pathway for early breast cancer patients
#
Cutting-edge science & AI
Publications in top scientific journals like Nature Medicine, Nature Communications, and Hepatology
#
Cutting-edge science & AI
Publications in top scientific journals like Nature Medicine, Nature Communications, and Hepatology
61
Academic partners
Across Canada, USA, France, Germany, Spain
141
KOLs
Close relationships with PIs including 141 KOLs with a mean H-index of 49
304
Well-funded
Million dollars raised from leading biopharma companies (Sanofi & BMS) and venture funds (Fidelity, Google Ventures & Bpifrance Large Ventures, among others)

Leadership team

We work together to outsmart disease

Meet our leadership team, scientific advisory board, and investors

Button

Learn more about what we do

AI-powered drug discovery

We develop state-of-the-art, AI-based computational technologies using rich multimodal patient data to discover new treatments.

Find out more
Button
Discovery

AI-powered drug development

We combine cutting-edge machine learning and biology to de-risk and accelerate clinical trials to advance drug development.

Find out more
Button
Development

A fuller patient picture

We deliver AI diagnostics that integrate seamlessly into the digital pathology workflow to support accurate and timely diagnosis.

Find out more
Button
Diagnostics